<DOC>
	<DOCNO>NCT02227732</DOCNO>
	<brief_summary>The purpose study determine whether new catheter safe effective treating malignant pleural effusion .</brief_summary>
	<brief_title>A Pilot Study Evaluating Safety Effectiveness New Pleural Catheter Medical Management Symptomatic , Recurrent , Malignant Pleural Effusions</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>1 . Subject ≥ 18 year old . 2 . Subject symptomatic malignant pleural effusion require intervention . For effusion define malignant , least one follow must true : There histocytological confirmation pleural malignancy The effusion exudate ( per Light 's criterion ) context histocytologically proven malignancy elsewhere , clear cause fluid identify 3 . Subject history least one ipsilateral pleural effusion cause dyspnoea respond thoracentesis lung expand dyspnoea relieve . 4 . Subject willing able provide write informed consent . 5 . Subject willing able meet study requirement , include attend followup visit receive trialrelated telephone call . 6 . There sufficient fluid thoracic ultrasound allow safe insertion indwell pleural catheter 7 . Negative pregnancy test appropriate 1 . Subject significant trap lung ( &gt; 20 % ) , proximal bronchial obstruction likely lead trap lung . 2 . Subject Karnofsky score less 50 , WHO/ECOG performance status 3* . 3 . Subject pregnant , plan become pregnant , lactate . 4 . Subject history empyema . 5 . Subject history chylothorax . 6 . Subject uncorrected coagulopathy . 7 . Subject allergic device material . 8 . Subject evidence , opinion Chief Investigator , either ongoing systemic pleural infection . 9 . Subject lobectomy pneumonectomy side effusion . 10 . Subject undergone previous attempt pleurodesis fail . 11 . Subject previously diagnose serious immunodeficiency disorder . 12 . Subject bilateral pleural effusion , least moderate size ( great 1/3 hemithorax chest xray ) . 13 . Subject evidence fluid loculation attempt pleurodesis likely futile . 14 . Subject mediastinal shift ≥2cm toward side effusion . 15 . Subject receive concurrent intrapleural chemotherapy radiation therapy ipsilateral chest . 16 . Subject clinical condition , diagnosis , social circumstance , opinion Chief Investigator , would mean participation study would contraindicate . 17 . Subject access telephone 18 . No detail blood value ( full blood count , clot screen , urea electrolyte , liver function ) within last 10 day * Patients performance status 3 may consider trial removal fluid would likely improve performance score 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>